Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials.
Carr L, Norris K, Parker H, Nilsson-Takeuchi A, Bryant D, Amarasinghe H, Kadalayil L, Else M, Pettitt A, Hillmen P, Schuh A, Walewska R, Baird DM, Oscier DG, Oakes CC, Gibson J, Pepper C, Strefford JC.
Carr L, et al. Among authors: baird dm.
Br J Haematol. 2024 Nov;205(5):2072-2076. doi: 10.1111/bjh.19765. Epub 2024 Sep 10.
Br J Haematol. 2024.
PMID: 39253978
No abstract available.